US Broker Ratings

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Growth Potential Amidst Robust Revenue Performance

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Based in Cincinnati, Ohio, and..

Labcorp Holdings Inc. (LH) Stock Analysis: Understanding the 10.56% Potential Upside

Investors seeking opportunities in the healthcare sector might find Labcorp Holdings Inc. (NYSE: LH) an intriguing option. As a leading company in the Diagnostics & Research..

BioNTech SE (BNTX) Stock Analysis: Exploring a 19.66% Potential Upside Amidst Biotech Volatility

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has been a focal point for investors seeking opportunities in the healthcare industry. Headquartered in..

Natera, Inc. (NTRA) Stock Analysis: Exploring Growth Potential Amidst Strong Revenue Growth

Natera, Inc. (NASDAQ: NTRA) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. The company, headquartered in Austin, Texas,..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating Growth with a 4.67% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector’s Diagnostics & Research industry, presents an intriguing opportunity for investors eyeing the life sciences..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 22.87% Upside Potential in Biotech Innovation

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology powerhouse, is capturing the attention of investors with its remarkable growth potential and innovative strides in oncology. With a..

The Cigna Group (CI) Stock Analysis: Exploring a 21% Potential Upside with Strong Buy Ratings

The Cigna Group (CI), a prominent player in the healthcare sector, has been capturing investor attention with its recent performance and promising potential upside. As the..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring Growth Potential in the Medical Instruments Industry

Becton, Dickinson and Company (NYSE: BDX), a giant in the healthcare sector, continues to capture investor attention with its significant role in developing and manufacturing medical..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 9.4% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, stands out with its robust market presence and significant growth potential. With a..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 21% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may find The Cooper Companies, Inc. (NYSE: COO) an intriguing prospect, particularly given the stock’s potential upside of 21.02%...

Neurocrine Biosciences (NBIX) Stock Analysis: Promising Upside with a 45.53% Potential Boost

Investors seeking opportunities in the healthcare sector may find Neurocrine Biosciences, Inc. (NBIX) an attractive candidate. With a robust market cap of $14.48 billion, this San..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 14.83% Upside Potential with Robust Revenue Growth

Royalty Pharma plc (NASDAQ: RPRX) stands as a unique player in the biotechnology sector, operating primarily as a buyer of biopharmaceutical royalties and a funder of..

Illumina, Inc. (ILMN) Stock Analysis: Navigating High Valuation and Strategic Collaborations

For investors considering a stake in Illumina, Inc. (NASDAQ: ILMN), a leading player in the healthcare sector’s diagnostics and research industry, the current landscape offers a..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating a 7.07% Potential Upside Amid Mixed Financials

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, is a notable name in the specialty and generic drug manufacturing industry. Headquartered..

argenx SE (ARGX) Stock Analysis: A Strong Buy with 39.93% Upside Potential

argenx SE (NASDAQ: ARGX), a prominent player in the biotechnology sector, has captured the attention of investors with its significant market capital of $51.88 billion and..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 40% Potential Upside in the Medical Devices Sector

Boston Scientific Corporation (NYSE: BSX) stands as a significant player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $61.93..

DaVita Inc. (DVA) Stock Analysis: Unveiling a 22% Upside and Robust ROE

DaVita Inc. (NYSE: DVA) stands as a significant player in the healthcare sector, specifically within the Medical Care Facilities industry. Renowned for its kidney dialysis services,..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating a Healthcare Giant with a 13.72% Potential Upside

Fresenius Medical Care AG (NYSE: FMS) stands as a pivotal player in the healthcare sector, primarily focused on providing dialysis and related services globally. Headquartered in..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A Healthcare Giant with Solid Growth Prospects and Buy Ratings

Thermo Fisher Scientific Inc (NYSE: TMO), a stalwart in the healthcare sector, continues to capture investor interest with its robust market presence and growth potential. With..

McKesson Corporation (MCK) Stock Analysis: Exploring a 4.46% Potential Upside in the Healthcare Giant

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, has captured investor attention with its robust performance and promising outlook. As one of the leading..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds